NYSE:TBI - Trueblue Stock Price, Price Target & More

Trueblue trades on the New York Stock Exchange (NYSE) under the ticker symbol "TBI."

Trueblue announced that its board has initiated a share repurchase plan on Tuesday, October 31st 2017, which authorizes the company to repurchase $100,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy shares of its stock through open market purchases. Shares repurchase plans are usually an indication that the company's board believes its shares are undervalued.

Trueblue Inc (NYSE:TBI) posted its quarterly earnings results on Monday, April, 30th. The business services provider reported $0.31 earnings per share for the quarter, topping the Zacks' consensus estimate of $0.22 by $0.09. The business services provider had revenue of $554.39 million for the quarter, compared to analysts' expectations of $570.40 million. Trueblue had a net margin of 2.39% and a return on equity of 13.81%. Trueblue's quarterly revenue was down 2.4% on a year-over-year basis. During the same period last year, the firm earned $0.21 earnings per share. View Trueblue's Earnings History.

Trueblue is scheduled to release their next quarterly earnings announcement on Monday, July, 30th 2018. View Earnings Estimates for Trueblue.

Trueblue issued an update on its second quarter earnings guidance on Monday, April, 30th. The company provided EPS guidance of $0.47-0.53 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.53. The company issued revenue guidance of $585-600 million, compared to the consensus revenue estimate of $627.25 million.

2 equities research analysts have issued 12 month target prices for Trueblue's stock. Their forecasts range from $26.00 to $29.00. On average, they expect Trueblue's share price to reach $27.50 in the next year. This suggests that the stock has a possible downside of 0.4%. View Analyst Ratings for Trueblue.

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Trueblue in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Some companies that are related to Trueblue include ASGN (ASGN), Insperity (NSP), Dometic Group AB (publ) (DTCGF), AMN Healthcare Services (AMN), TTEC (TTEC), Kforce (KFRC), Kelly Services, Inc. Class B (KELYB), Kelly Services, Inc. Class A (KELYA), Barrett Business Services (BBSI), SThree (STREF), Cross Country Healthcare (CCRN), StarTek (SRT), DLH (DLHC), R C M Technologies (RCMT) and Hudson Global (HSON).

Headlines about TBI stock have been trending somewhat positive recently, Accern reports. The research firm rates the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Trueblue earned a news sentiment score of 0.10 on Accern's scale. They also assigned news headlines about the business services provider an impact score of 46.32 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Trueblue's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include James Investment Research Inc. (0.36%), Bank of Montreal Can (0.29%), Municipal Employees Retirement System of Michigan (0.05%), Alpha Windward LLC (0.05%) and Cornerstone Wealth Management LLC (0.03%). Company insiders that own Trueblue stock include Bonnie W Soodik, Derrek Lane Gafford, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Institutional Ownership Trends for Trueblue.

TBI stock was sold by a variety of institutional investors in the last quarter, including Municipal Employees Retirement System of Michigan and Bank of Montreal Can. Company insiders that have sold Trueblue company stock in the last year include Bonnie W Soodik, James E Defebaugh, Joseph P Sambataro Jr, Steven C Cooper, Taryn R Owen and Wayne W Larkin. View Insider Buying and Selling for Trueblue.

TBI stock was purchased by a variety of institutional investors in the last quarter, including James Investment Research Inc., Cornerstone Wealth Management LLC and Alpha Windward LLC. View Insider Buying and Selling for Trueblue.

Shares of TBI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of TBI stock can currently be purchased for approximately $27.60.

Trueblue has a market capitalization of $1.14 billion and generates $2.51 billion in revenue each year. The business services provider earns $55.45 million in net income (profit) each year or $1.74 on an earnings per share basis. Trueblue employs 5,500 workers across the globe.

Trueblue's mailing address is 1015 A STREET, TACOMA WA, 98402. The business services provider can be reached via phone at 253-383-9101 or via email at [email protected]